MELISSA BECK: Open Payments
NPI 1912948290 · MONROE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,341 in 113 payments from 21 companies in 2025. Trend: 2023 $2,595 · 2024 $2,347 · 2025 $2,341
Food & beverage: $2,341
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $430 |
| Novo Nordisk Inc | 15 | $290 |
| AstraZeneca Pharmaceuticals LP | 10 | $276 |
| Lilly USA, LLC | 16 | $252 |
| GlaxoSmithKline, LLC. | 12 | $199 |
| E.R. Squibb & Sons, L.L.C. | 7 | $183 |
| PFIZER INC. | 9 | $140 |
| Abbott Laboratories | 8 | $137 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $67 |
| LNHC, Inc | 1 | $65 |
Products named: UBRELVY, JARDIANCE, TRELEGY ELLIPTA, FARXIGA, FREESTYLE LIBRE, QULIPTA, ELIQUIS, Rybelsus.
Industry payments across NY — which companies pay providers there.
